CATALAYER NEWS
Pfizer, Arvinas lose interest in commercializing PROTAC inhibitor, leading to layoffs at the biotech - Fierce Biotech
Source: Fierce Biotech · 2025-09-18
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Mentioned Tickers
$PFE · PfizerRelated Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets